Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans
- Conditions
- Interventions
- First Posted Date
- 2011-12-28
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT01500317
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Kati Järvelä
- Target Recruit Count
- 165
- Registration Number
- NCT01374763
- Locations
- 🇫🇮
Tampere University Hospital Heart Center, Tampere, Finland
Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back Pain
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Azienda Sanitaria Locale 4, Teramo
- Target Recruit Count
- 250
- Registration Number
- NCT01344720
- Locations
- 🇮🇹
Unità di riabilitazione neurofisiologica Istituto Scientifico di Riabilitazione di Montescano, Montescano (PV), Pavia, Italy
🇮🇹Dipartimento di Scienze della Salute Anestesia, Rianimazione e Terapia del dolore - Università degli Studi di L'Aquila Ospedale San Salvatore L'Aquila, L'Aquila, Italy
🇮🇹Clinica Anestesia e Rianimazione Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Roma, Italy
Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2015-08-11
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 240
- Registration Number
- NCT01304134
- Locations
- 🇨🇳
Investigational site, Beijing, Beijing, China
The Addition of Oral Analgesics to LET During Laceration Repair
- Conditions
- Interventions
- First Posted Date
- 2010-12-31
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Children's Hospitals and Clinics of Minnesota
- Target Recruit Count
- 150
- Registration Number
- NCT01268670
- Locations
- 🇺🇸
Children's Hospitals and Clinics of Minnesota, Minneapolis and St Paul, Minnesota, United States
A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy
- Conditions
- Interventions
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Ullevaal University Hospital
- Target Recruit Count
- 85
- Registration Number
- NCT01109511
- Locations
- 🇳🇴
Dept of Anesthesiology, Oslo University Hospital, Ullevaal, Oslo, Norway
OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2012-02-16
- Lead Sponsor
- Mundipharma Oy
- Target Recruit Count
- 137
- Registration Number
- NCT01083485
- Locations
- 🇫🇮
Central hospital of Pori, Pori, Finland
Oxycodone for Labor Pain - Pharmacokinetics (PK), Safety and Efficacy
- First Posted Date
- 2009-11-20
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Kuopio University Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT01016821
- Locations
- 🇫🇮
Kuopio University Hospital, Kuopio, Finland
Tanezumab In Osteoarthritis Of The Hip Or Knee
- Conditions
- Interventions
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 614
- Registration Number
- NCT00985621
- Locations
- 🇺🇸
Clinical Pharmacology Study Group, Worcester, Massachusetts, United States
🇺🇸Providence Clinical Research, Burbank, California, United States
🇺🇸Valley Research, Fresno, California, United States
Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT00964808
- Locations
- 🇩🇰
Orthopaedic Department, Vejle, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.